Zydus Lifesciences Ltd (ZYDUSLIFE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 290229,
    "name": "Zydus Lifesci.",
    "stock_name": "Zydus Lifesci.",
    "full_name": "Zydus Lifesciences Ltd",
    "name_url": "stocks-analysis/zydus-lifesci",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "956.95",
    "chg": 16.9,
    "chgp": "1.8%",
    "dir": 1,
    "prev_price": "940.05",
    "mcapval": "93,716.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532321,
    "symbol": "ZYDUSLIFE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE010B01027",
    "curr_date": "May 11",
    "curr_time": "",
    "bse_nse_vol": "10.05 lacs",
    "exc_status": "Active",
    "traded_date": "May 11, 2026",
    "traded_date_str": "2026 05 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/zydus-lifesci-290229-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Zydus Lifesciences Ltd Valuation Shifts: From Attractive to Fair Amid Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-valuation-shifts-from-attractive-to-fair-amid-sector-dynamics-3978630",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_valuationdot_3978630.png",
        "date": "2026-05-07 08:00:39",
        "description": "Zydus Lifesciences Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating as of December 2025. This change reflects evolving market perceptions amid a competitive Pharmaceuticals & Biotechnology sector, with key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios signalling a moderation in price attractiveness relative to historical and peer benchmarks."
      },
      {
        "title": "Zydus Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zydus-lifesciences-ltd-is-rated-sell-3973338",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_mojoScore_3973338.png",
        "date": "2026-05-04 10:10:03",
        "description": "Zydus Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Zydus Lifesciences Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-amid-mixed-market-signals-3966790",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ZydusLifescienc_oi_spurts_by_underlying_3966790.png",
        "date": "2026-04-28 15:00:08",
        "description": "Zydus Lifesciences Ltd has witnessed a notable 13% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock underperformed its sector and broader indices, reflecting a complex interplay between bullish bets and profit-taking pressures."
      },
      {
        "title": "Zydus Lifesciences Sees Sharp Open Interest Surge Amid Bearish Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-amid-bearish-market-signals-3966746",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ZydusLifescienc_oi_spurts_by_underlying_3966746.png",
        "date": "2026-04-28 14:00:08",
        "description": "Zydus Lifesciences Ltd has witnessed a notable 11.3% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this surge, the stock underperformed its sector and broader indices, reflecting a complex interplay of bullish and bearish bets among traders."
      },
      {
        "title": "Zydus Lifesciences Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-amid-mixed-market-signals-3966687",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ZydusLifescienc_oi_spurts_by_underlying_3966687.png",
        "date": "2026-04-28 13:00:08",
        "description": "Zydus Lifesciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 11.24% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this increase, the stock underperformed its sector and broader benchmarks, reflecting a complex interplay of market sentiment and technical factors."
      },
      {
        "title": "Zydus Lifesciences Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-amid-mixed-market-signals-3966659",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ZydusLifescienc_oi_spurts_by_underlying_3966659.png",
        "date": "2026-04-28 12:00:06",
        "description": "Zydus Lifesciences Ltd has witnessed a notable 11.5% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this surge, the stock underperformed its sector and broader indices, reflecting a complex interplay of market sentiment and technical factors."
      },
      {
        "title": "Zydus Lifesciences Sees Sharp Open Interest Surge Amid Bullish Derivatives Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-amid-bullish-derivatives-activity-3964649",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ZydusLifescienc_oi_spurts_by_underlying_3964649.png",
        "date": "2026-04-27 15:00:10",
        "description": "Zydus Lifesciences Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent price action, combined with rising volumes and improved moving averages, suggests a cautiously optimistic outlook despite a recent downgrade in its Mojo Grade to Sell."
      },
      {
        "title": "Zydus Lifesciences Sees Significant Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-significant-open-interest-surge-amid-mixed-market-signals-3961130",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ZydusLifescienc_oi_spurts_by_underlying_3961130.png",
        "date": "2026-04-24 15:00:17",
        "description": "Zydus Lifesciences Ltd has witnessed a notable 14.3% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this increase, the stock underperformed its sector and broader indices, reflecting a complex interplay of bullish and bearish sentiments among traders."
      },
      {
        "title": "Zydus Lifesciences Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-amid-mixed-market-signals-3961008",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ZydusLifescienc_oi_spurts_by_underlying_3961008.png",
        "date": "2026-04-24 14:00:09",
        "description": "Zydus Lifesciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a notable 12.9% surge in open interest (OI) in its derivatives segment on 24 Apr 2026, signalling heightened market activity and shifting investor positioning. Despite this spike, the stock underperformed its sector and broader indices, reflecting a complex interplay of bullish and bearish bets among traders."
      }
    ],
    "total": 645,
    "sid": "290229",
    "stock_news_url": "https://www.marketsmojo.com/news/zydus-lifesciences-290229"
  },
  "announcements": [
    {
      "details": "Cadila Healthcare Limited has informed the Exchange regarding Disclosure of Consolidated Related Party Transactions for the half year ended on September 30, 2019.",
      "source": "NSE",
      "caption": "Cadila Healthcare Limited - Other General Purpose",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Cadila Healthcare Limited has informed the Exchange regarding a press release dated December 05, 2019, titled \"Zydus announces regulatory filing of Saroglitazar Magnesium for treatment of NASH with DCGI\".",
      "source": "NSE",
      "caption": "Cadila Healthcare Limited - Press Release",
      "datetime": "05-Dec-2019"
    },
    {
      "details": "Cadila Healthcare Limited has informed the Exchange regarding a press release dated December 03, 2019, titled \"Zydus receives tentative approval from the USFDA for Lorcaserin Hydrochloride Tablets\".",
      "source": "NSE",
      "caption": "Cadila Healthcare Limited - Press Release",
      "datetime": "03-Dec-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "19 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has declared <strong>1100%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has announced <strong>1:5</strong> stock split, ex-date: 06 Oct 15",
          "dt": "2015-10-06",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 05 Apr 10",
          "dt": "2010-04-05",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Zydus Lifesciences Ltd Valuation Shifts: From Attractive to Fair Amid Sector Dynamics

2026-05-07 08:00:39

Zydus Lifesciences Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating as of December 2025. This change reflects evolving market perceptions amid a competitive Pharmaceuticals & Biotechnology sector, with key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios signalling a moderation in price attractiveness relative to historical and peer benchmarks.

Read full news article

Zydus Lifesciences Ltd is Rated Sell

2026-05-04 10:10:03

Zydus Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Zydus Lifesciences Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-04-28 15:00:08

Zydus Lifesciences Ltd has witnessed a notable 13% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock underperformed its sector and broader indices, reflecting a complex interplay between bullish bets and profit-taking pressures.

Read full news article

Zydus Lifesciences Sees Sharp Open Interest Surge Amid Bearish Market Signals

2026-04-28 14:00:08

Zydus Lifesciences Ltd has witnessed a notable 11.3% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this surge, the stock underperformed its sector and broader indices, reflecting a complex interplay of bullish and bearish bets among traders.

Read full news article

Zydus Lifesciences Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-04-28 13:00:08

Zydus Lifesciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 11.24% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this increase, the stock underperformed its sector and broader benchmarks, reflecting a complex interplay of market sentiment and technical factors.

Read full news article

Zydus Lifesciences Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-04-28 12:00:06

Zydus Lifesciences Ltd has witnessed a notable 11.5% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this surge, the stock underperformed its sector and broader indices, reflecting a complex interplay of market sentiment and technical factors.

Read full news article

Zydus Lifesciences Sees Sharp Open Interest Surge Amid Bullish Derivatives Activity

2026-04-27 15:00:10

Zydus Lifesciences Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent price action, combined with rising volumes and improved moving averages, suggests a cautiously optimistic outlook despite a recent downgrade in its Mojo Grade to Sell.

Read full news article

Zydus Lifesciences Sees Significant Open Interest Surge Amid Mixed Market Signals

2026-04-24 15:00:17

Zydus Lifesciences Ltd has witnessed a notable 14.3% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this increase, the stock underperformed its sector and broader indices, reflecting a complex interplay of bullish and bearish sentiments among traders.

Read full news article

Zydus Lifesciences Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-04-24 14:00:09

Zydus Lifesciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a notable 12.9% surge in open interest (OI) in its derivatives segment on 24 Apr 2026, signalling heightened market activity and shifting investor positioning. Despite this spike, the stock underperformed its sector and broader indices, reflecting a complex interplay of bullish and bearish bets among traders.

Read full news article

View All News